MTOR and type 2 diabetes mellitus: For example, unsupervised analysis of skeletal muscle transcriptomics from T2D patients has been clustered into subtypes with elevated myokine expression influencing hepatic gluconeogenesis and altered AMPK/mTOR signaling pathways that regulate cross‐tissue glucose uptake and usage.